O-1663 inhibitor of advanced stages of breast cancer. It acts by targeting multiple cannabinoid anti-tumour pathways. References: Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Martinez-Martinez E, Amere M, Gujjar R, Mahadevan A, Desprez PY, McAllister SD. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br J Pharmacol. 2014 Oct;171(19):4464-77. doi: 10.1111/bph.12803. Epub 2014 Sep 5. PubMed PMID: 24910342; PubMed Central PMCID: PMC4209152.

纯度：≥98%

CAS：468083-84-3